Sargassum horneri is rich in bioactive compounds, including phytosterols, exhibits antioxidant, anti-obesity and anti-inflammation properties; however, its underlying mechanisms remain unclear. In this study, we evaluated that the antioxidant and anti-inflammatory effect of S. horneri ethanolic extract and its subfractions using lipopolysaccharide (LPS)-treated RAW264.7 cells. Furthermore, we examined the in vivo anti-obesity efficacy of S. horneri using obese mice fed a high-fat diet. Results revealed that the in vitro treatment increases the inflammatory cytokines such as inducible nitric oxide synthase (iNOS), nitric oxide (NO), cyclooxygenase-2 (COX-2), prostaglandin E2 (PGE(2)), tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6) including nuclear factor kappa B (NF-κB) subunit p65 protein expressions in LPS treated RAW264.7 cells. However, these pro-inflammatory cytokines were significantly reduced by inhibiting the NF-κB- p65 translocation pathway in S. horneri treatment. In addition, the S. horneri extracts increased the nuclear factor erythroid 2-related factor 2 (Nrf2) translocation into the nucleus as well as their heme oxygenase (HO-1) target gene expression. Whereas, in vivo treatment with S. horneri reduces body and organ weight, including pathological damage in liver and adipose tissue. Moreover, S. horneri decreases serum triglycerides (TG), LDL-cholesterol, total cholesterol (TC), arteriosclerosis index (AI), and cardiovascular risk factor (CVRF), but increases HDL-cholesterol concentration-dependently. The liver antioxidant enzyme activities and AMP-activated protein kinase (AMPK) protein expressions were raised in S. horneri treated groups; while sterol regulatory element-binding protein-1 (SREBP-1), Fatty acid synthase (FAS), and Acetyl-CoA carboxylase (ACC) expressions was reduced with dose-dependent manner. These findings provide an innovative pharmacological basis for the antioxidant, anti-inflammatory and anti-obesity effect of S. horneri. It specifies the potential of S. horneri as a candidate for preventing inflammation, obesity and other related disorders.
Bioactive compounds from Sargassum horneri attenuates inflammation and obesity regulating by Nrf2/HO-1 and AMPK signaling pathways.
阅读:2
作者:Chilakala Ramakrishna, Moon Hyeon Jeong, Kim Min Ju, Ko Kang Ho, Han Jong Won, Jung Min Seouk, Cheong Sun Hee
| 期刊: | Scientific Reports | 影响因子: | 3.900 |
| 时间: | 2025 | 起止号: | 2025 Dec 10; 15(1):43519 |
| doi: | 10.1038/s41598-025-27131-5 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
